AbbVie

FDA approves AbbVie’s hepatitis treatment
Marketwatch
Fri, 12/19/14 - 03:58 pm
FDA
AbbVie
hepatitis C
Viekira Pak
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
AbbVie: Here’s How It Could Differentiate Itself From Gilead
Barron's
Thu, 12/18/14 - 04:04 pm
AbbVie
Gilead Sciences
hepatitis C
drug pricing
Banks lost big betting on canceled AbbVie-Shire merger
Fierce Pharma
Mon, 12/15/14 - 06:58 pm
AbbVie
Shire
M&A
Could the World's Top-Selling Drug Be Toppled?
Motley Fool
Mon, 12/15/14 - 09:03 am
AbbVie
Humira
Cadila
biosimilars
Sovaldi
Harvoni
Gilead Sciences
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Sat, 12/13/14 - 11:29 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Fri, 12/12/14 - 07:17 pm
hepatitis C
Gilead Sciences
Sovaldi
Harvoni
AbbVie
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
AbbVie
Gilead Sciences
Achillion
hepatitis C
Gilead Sciences: Still Waiting on AbbVie
Barron's
Tue, 12/9/14 - 04:03 pm
Gilead Sciences
AbbVie
hepatitis C
India's Cadila launches first cheaper copy of world's top-selling drug
Yahoo/Reuters
Tue, 12/9/14 - 07:51 am
India
Cadila
AbbVie
Humira
biosimilars
AbbVie oncology pipeline continues to show progress
Medical Marketing and Media
Mon, 12/8/14 - 11:21 pm
AbbVie
oncology
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Sovaldi
AbbVie
Gilead Sciences
hepatitis C
AbbVie adds children's AIDS drugs to shared patent pool
Yahoo/Reuters
Mon, 12/1/14 - 07:56 am
AbbVie
AIDS
patents
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
Yahoo
Fri, 11/21/14 - 08:12 am
AbbVie
Singapore
drug manufacturing
Asia
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Fri, 11/14/14 - 09:53 am
M&A
AbbVie
Shire
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
hepatitis C
AbbVie
Achillion
Gilead Sciences
Merck
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
AbbVie
hepatitis C
ombitasvir
ritonavir
dasabuvir
ABT-450
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C

Pages